Terray Therapeutics pricing

No price exists, as the company sells no product and runs no commercial platform for external licensing. Revenue comes from pharmaceutical research collaborations, and the partners are named and dated: a discovery milestone achieved with Bristol Myers Squibb in December 2025, a multi target research collaboration with Gilead from December 2024, a transcription factor collaboration with Odyssey Therapeutics from October 2024, and an earlier multi target collaboration with Calico announced in October 2022.

Terray Therapeutics full profile Terray Therapeutics alternatives

Pricing terms

How Terray Therapeutics pricing works

Pricing model: Not applicable. Preclinical therapeutics developer funded by venture capital, with revenue through pharmaceutical partnerships rather than product or software sales.
Implementation: Not applicable. No customer deployment exists.
Business associate agreement: Not applicable. No covered entity customers and no business associate relationship.

No upfront payments, milestone structures or royalty terms are disclosed for any of them, so the economic weight of the partnership book cannot be assessed from public material. Capital disclosure is complete: a previously unannounced seed round co led by Digitalis Ventures and Two Sigma Ventures, a $60 million Series A led by Madrona Venture Group in February 2022, and a $120 million Series B in October 2024 led by Bedford Ridge Capital and NVentures, with total equity financing since inception stated at more than $200 million. Several platform assets are published free rather than licensed: the COATI foundation model, the latent diffusion generator and the molecule selection method are all released as open source code.

Compared on price

Terray Therapeutics pricing against its alternatives

Published prices for Terray Therapeutics and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.

All Terray Therapeutics alternatives →

T
Terray TherapeuticsNot applicable
P
PostEraNo published price
S
Superluminal MedicinesNo published price
C
CellarityNot applicable
V
Variational AICustom project pricing
G
Genesis Molecular AINo published price
N
Numerion LabsNo published price
C
ChemifyNo published price
L
Lila SciencesNo published price

Questions

Terray Therapeutics pricing, answered

How much does Terray Therapeutics cost?

Terray Therapeutics does not publish a price. Revenue comes from pharmaceutical research collaborations, and the partners are named and dated: a discovery milestone achieved with Bristol Myers Squibb in December 2025, a multi target research collaboration with Gilead from December 2024, a transcription factor collaboration with Odyssey Therapeutics from October 2024, and an earlier multi target collaboration with Calico announced in October 2022.

Does Terray Therapeutics offer a business associate agreement?

Not applicable. No covered entity customers and no business associate relationship.